Cargando…
Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase
[Image: see text] We report an alternative approach to the unnatural nucleobase fragment seen in remdesivir (Veklury). Remdesivir displays broad-spectrum antiviral activity and is currently being evaluated in Phase III clinical trials to treat patients with COVID-19. Our route relies on the formatio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653677/ https://www.ncbi.nlm.nih.gov/pubmed/33085486 http://dx.doi.org/10.1021/acs.orglett.0c03052 |
_version_ | 1783607920826515456 |
---|---|
author | Knapp, Rachel R. Tona, Veronica Okada, Taku Sarpong, Richmond Garg, Neil K. |
author_facet | Knapp, Rachel R. Tona, Veronica Okada, Taku Sarpong, Richmond Garg, Neil K. |
author_sort | Knapp, Rachel R. |
collection | PubMed |
description | [Image: see text] We report an alternative approach to the unnatural nucleobase fragment seen in remdesivir (Veklury). Remdesivir displays broad-spectrum antiviral activity and is currently being evaluated in Phase III clinical trials to treat patients with COVID-19. Our route relies on the formation of a cyanoamidine intermediate, which undergoes Lewis acid-mediated cyclization to yield the desired nucleobase. The approach is strategically distinct from prior routes and could further enable the synthesis of remdesivir and other small-molecule therapeutics. |
format | Online Article Text |
id | pubmed-7653677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American
Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-76536772020-11-12 Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase Knapp, Rachel R. Tona, Veronica Okada, Taku Sarpong, Richmond Garg, Neil K. Org Lett [Image: see text] We report an alternative approach to the unnatural nucleobase fragment seen in remdesivir (Veklury). Remdesivir displays broad-spectrum antiviral activity and is currently being evaluated in Phase III clinical trials to treat patients with COVID-19. Our route relies on the formation of a cyanoamidine intermediate, which undergoes Lewis acid-mediated cyclization to yield the desired nucleobase. The approach is strategically distinct from prior routes and could further enable the synthesis of remdesivir and other small-molecule therapeutics. American Chemical Society 2020-10-21 2020-11-06 /pmc/articles/PMC7653677/ /pubmed/33085486 http://dx.doi.org/10.1021/acs.orglett.0c03052 Text en © 2020 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. |
spellingShingle | Knapp, Rachel R. Tona, Veronica Okada, Taku Sarpong, Richmond Garg, Neil K. Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase |
title | Cyanoamidine Cyclization Approach to Remdesivir’s
Nucleobase |
title_full | Cyanoamidine Cyclization Approach to Remdesivir’s
Nucleobase |
title_fullStr | Cyanoamidine Cyclization Approach to Remdesivir’s
Nucleobase |
title_full_unstemmed | Cyanoamidine Cyclization Approach to Remdesivir’s
Nucleobase |
title_short | Cyanoamidine Cyclization Approach to Remdesivir’s
Nucleobase |
title_sort | cyanoamidine cyclization approach to remdesivir’s
nucleobase |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653677/ https://www.ncbi.nlm.nih.gov/pubmed/33085486 http://dx.doi.org/10.1021/acs.orglett.0c03052 |
work_keys_str_mv | AT knapprachelr cyanoamidinecyclizationapproachtoremdesivirsnucleobase AT tonaveronica cyanoamidinecyclizationapproachtoremdesivirsnucleobase AT okadataku cyanoamidinecyclizationapproachtoremdesivirsnucleobase AT sarpongrichmond cyanoamidinecyclizationapproachtoremdesivirsnucleobase AT gargneilk cyanoamidinecyclizationapproachtoremdesivirsnucleobase |